Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-27

FDA Approved: NURTEC ODT — Original Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

The FDA approves Nurtec ODT (rimegepant sulfate) under its original NDA for the acute treatment of migraine in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NURTEC ODT (RIMEGEPANT SULFATE)

Snippet

ORIG AP for NURTEC ODT (RIMEGEPANT SULFATE)